Form 4 for KRYS Krystal Biotech, Inc.
Accepted 2024-02-28 00:00:00 ET · period of report 2024-02-26 · accession 0001298709-24-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-28 | 2024-02-26 | KRYS | Krishnan Krish S | Pres, CEO, Dir, 10% | F - Tax | $157.00 | -3,791 | 1.63M | -0.2% | -$595.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-26 | F | D | 3,791 | $157.00 | 1,630,547 | D | — | — | (F1) Represents number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 10,200 shares of restricted stock on February 26, 2024. (F2) The closing price on February 26, 2024 of the Company's common stock on NASDAQ. |